Company intelligence / Profile preview

Neoteryx

Torrance, California, USA

Ownership: Private
Development stage: Other

Overview

Neoteryx does not develop therapeutic drugs but commercializes CE/IVD and FDA Class I microsampling devices (e.g., Mitra) for quantitative remote collection of small-volume blood and other biological samples that are widely used in pharmaceutical development, clinical research, therapeutic drug monitoring, and decentralized/virtual healthcare models.[1][2][3][4][6]

Modalities: DeviceNon-pharmacological therapy
Industry: Consumable Medical Devices

Partnerships

Partnerships with NIH and Charles River on use of Mitra devices with VAMS in drug discovery, development, clinical research, and public health programs[3]Partnership with Cellecta to introduce a finger-prick blood test for comprehensive whole‑genome expression profiling using Mitra devices[5]

Beyond the preview

Go deeper on Neoteryx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neoteryx.

Explore the full profile